Arena Capital Advisors’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,717
| Closed | -$57.7K | – | 147 |
|
|
2022
Q4 | $57.7K | Hold |
5,717
| – | – | 0.03% | 80 |
|
|
2022
Q3 | $57K | Hold |
5,717
| – | – | 0.02% | 127 |
|
|
2022
Q2 | $56K | Sell |
5,717
-98,025
| -94% | -$960K | 0.01% | 153 |
|
|
2022
Q1 | $1.01M | Sell |
103,742
-197,157
| -66% | -$1.93M | 0.15% | 121 |
|
|
2021
Q4 | $2.92M | Hold |
300,899
| – | – | 0.27% | 123 |
|
|
2021
Q3 | $2.93M | Buy |
300,899
+225,899
| +301% | +$2.2M | 0.23% | 134 |
|
|
2021
Q2 | $731K | Buy |
+75,000
| New | +$731K | 0.06% | 262 |
|